Tags: Drug.

Trametinib (trade name Mekinist) is a cancer drug. It is a MEK inhibitor drug with anti-cancer activity.It inhibits MEK1 and MEK2.Trametinib had good results for metastatic melanoma carrying the BRAF V600E mutation in a phase III clinical trial.

Trametinib.svg
ATC prefix
L01
ATC suffix
XE25
CAS number
871700-17-3
ChEBI
75998
FDA UNII code
33E86K87QN
IUPAC name
N-(3-3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-68-dimethyl-247-trioxo-3467-tetrahydropyrido[43-d]pyrimidin-1(2H)-ylphenyl)acetamide
PubChem
11707110

Loading...

This page contains content from the copyrighted Wikipedia article "Trametinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.